HB3613 EngrossedLRB103 30213 RJT 56641 b

1    AN ACT concerning education.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 5. The School Code is amended by changing Section
522-30 as follows:
 
6    (105 ILCS 5/22-30)
7    Sec. 22-30. Self-administration and self-carry of asthma
8medication and epinephrine injectors; administration of
9undesignated epinephrine injectors; administration of an
10opioid antagonist; administration of undesignated asthma
11medication; asthma episode emergency response protocol.
12    (a) For the purpose of this Section only, the following
13terms shall have the meanings set forth below:
14    "Asthma action plan" means a written plan developed with a
15pupil's medical provider to help control the pupil's asthma.
16The goal of an asthma action plan is to reduce or prevent
17flare-ups and emergency department visits through day-to-day
18management and to serve as a student-specific document to be
19referenced in the event of an asthma episode.
20    "Asthma episode emergency response protocol" means a
21procedure to provide assistance to a pupil experiencing
22symptoms of wheezing, coughing, shortness of breath, chest
23tightness, or breathing difficulty.

 

 

HB3613 Engrossed- 2 -LRB103 30213 RJT 56641 b

1    "Epinephrine injector" includes an auto-injector approved
2by the United States Food and Drug Administration for the
3administration of epinephrine and a pre-filled syringe
4approved by the United States Food and Drug Administration and
5used for the administration of epinephrine that contains a
6pre-measured dose of epinephrine that is equivalent to the
7dosages used in an auto-injector.
8    "Asthma medication" means quick-relief asthma medication,
9including albuterol or other short-acting bronchodilators,
10that is approved by the United States Food and Drug
11Administration for the treatment of respiratory distress.
12"Asthma medication" includes medication delivered through a
13device, including a metered dose inhaler with a reusable or
14disposable spacer or a nebulizer with a mouthpiece or mask.
15    "Opioid antagonist" means a drug that binds to opioid
16receptors and blocks or inhibits the effect of opioids acting
17on those receptors, including, but not limited to, naloxone
18hydrochloride or any other similarly acting drug approved by
19the U.S. Food and Drug Administration.
20    "Respiratory distress" means the perceived or actual
21presence of wheezing, coughing, shortness of breath, chest
22tightness, breathing difficulty, or any other symptoms
23consistent with asthma. Respiratory distress may be
24categorized as "mild-to-moderate" or "severe".
25    "School nurse" means a registered nurse working in a
26school with or without licensure endorsed in school nursing.

 

 

HB3613 Engrossed- 3 -LRB103 30213 RJT 56641 b

1    "Self-administration" means a pupil's discretionary use of
2his or her prescribed asthma medication or epinephrine
3injector.
4    "Self-carry" means a pupil's ability to carry his or her
5prescribed asthma medication or epinephrine injector.
6    "Standing protocol" may be issued by (i) a physician
7licensed to practice medicine in all its branches, (ii) a
8licensed physician assistant with prescriptive authority, or
9(iii) a licensed advanced practice registered nurse with
10prescriptive authority.
11    "Trained personnel" means any school employee or volunteer
12personnel authorized in Sections 10-22.34, 10-22.34a, and
1310-22.34b of this Code who has completed training under
14subsection (g) of this Section to recognize and respond to
15anaphylaxis, an opioid overdose, or respiratory distress.
16    "Undesignated asthma medication" means asthma medication
17prescribed in the name of a school district, public school,
18charter school, or nonpublic school.
19    "Undesignated epinephrine injector" means an epinephrine
20injector prescribed in the name of a school district, public
21school, charter school, or nonpublic school.
22    (b) A school, whether public, charter, or nonpublic, must
23permit the self-administration and self-carry of asthma
24medication by a pupil with asthma or the self-administration
25and self-carry of an epinephrine injector by a pupil, provided
26that:

 

 

HB3613 Engrossed- 4 -LRB103 30213 RJT 56641 b

1        (1) the parents or guardians of the pupil provide to
2    the school (i) written authorization from the parents or
3    guardians for (A) the self-administration and self-carry
4    of asthma medication or (B) the self-carry of asthma
5    medication or (ii) for (A) the self-administration and
6    self-carry of an epinephrine injector or (B) the
7    self-carry of an epinephrine injector, written
8    authorization from the pupil's physician, physician
9    assistant, or advanced practice registered nurse; and
10        (2) the parents or guardians of the pupil provide to
11    the school (i) the prescription label, which must contain
12    the name of the asthma medication, the prescribed dosage,
13    and the time at which or circumstances under which the
14    asthma medication is to be administered, or (ii) for the
15    self-administration or self-carry of an epinephrine
16    injector, a written statement from the pupil's physician,
17    physician assistant, or advanced practice registered nurse
18    containing the following information:
19            (A) the name and purpose of the epinephrine
20        injector;
21            (B) the prescribed dosage; and
22            (C) the time or times at which or the special
23        circumstances under which the epinephrine injector is
24        to be administered.
25The information provided shall be kept on file in the office of
26the school nurse or, in the absence of a school nurse, the

 

 

HB3613 Engrossed- 5 -LRB103 30213 RJT 56641 b

1school's administrator.
2    (b-5) A school district, public school, charter school, or
3nonpublic school may authorize the provision of a
4student-specific or undesignated epinephrine injector to a
5student or any personnel authorized under a student's
6Individual Health Care Action Plan, Illinois Food Allergy
7Emergency Action Plan and Treatment Authorization Form, or
8plan pursuant to Section 504 of the federal Rehabilitation Act
9of 1973 to administer an epinephrine injector to the student,
10that meets the student's prescription on file.
11    (b-10) The school district, public school, charter school,
12or nonpublic school may authorize a school nurse or trained
13personnel to do the following: (i) provide an undesignated
14epinephrine injector to a student for self-administration only
15or any personnel authorized under a student's Individual
16Health Care Action Plan, Illinois Food Allergy Emergency
17Action Plan and Treatment Authorization Form, plan pursuant to
18Section 504 of the federal Rehabilitation Act of 1973, or
19individualized education program plan to administer to the
20student that meets the student's prescription on file; (ii)
21administer an undesignated epinephrine injector that meets the
22prescription on file to any student who has an Individual
23Health Care Action Plan, Illinois Food Allergy Emergency
24Action Plan and Treatment Authorization Form, plan pursuant to
25Section 504 of the federal Rehabilitation Act of 1973, or
26individualized education program plan that authorizes the use

 

 

HB3613 Engrossed- 6 -LRB103 30213 RJT 56641 b

1of an epinephrine injector; (iii) administer an undesignated
2epinephrine injector to any person that the school nurse or
3trained personnel in good faith believes is having an
4anaphylactic reaction; (iv) administer an opioid antagonist to
5any person that the school nurse or trained personnel in good
6faith believes is having an opioid overdose; (v) provide
7undesignated asthma medication to a student for
8self-administration only or to any personnel authorized under
9a student's Individual Health Care Action Plan or asthma
10action plan, plan pursuant to Section 504 of the federal
11Rehabilitation Act of 1973, or individualized education
12program plan to administer to the student that meets the
13student's prescription on file; (vi) administer undesignated
14asthma medication that meets the prescription on file to any
15student who has an Individual Health Care Action Plan or
16asthma action plan, plan pursuant to Section 504 of the
17federal Rehabilitation Act of 1973, or individualized
18education program plan that authorizes the use of asthma
19medication; and (vii) administer undesignated asthma
20medication to any person that the school nurse or trained
21personnel believes in good faith is having respiratory
22distress.
23    (c) The school district, public school, charter school, or
24nonpublic school must inform the parents or guardians of the
25pupil, in writing, that the school district, public school,
26charter school, or nonpublic school and its employees and

 

 

HB3613 Engrossed- 7 -LRB103 30213 RJT 56641 b

1agents, including a physician, physician assistant, or
2advanced practice registered nurse providing standing protocol
3and a prescription for school epinephrine injectors, an opioid
4antagonist, or undesignated asthma medication, are to incur no
5liability or professional discipline, except for willful and
6wanton conduct, as a result of any injury arising from the
7administration of asthma medication, an epinephrine injector,
8or an opioid antagonist regardless of whether authorization
9was given by the pupil's parents or guardians or by the pupil's
10physician, physician assistant, or advanced practice
11registered nurse. The parents or guardians of the pupil must
12sign a statement acknowledging that the school district,
13public school, charter school, or nonpublic school and its
14employees and agents are to incur no liability, except for
15willful and wanton conduct, as a result of any injury arising
16from the administration of asthma medication, an epinephrine
17injector, or an opioid antagonist regardless of whether
18authorization was given by the pupil's parents or guardians or
19by the pupil's physician, physician assistant, or advanced
20practice registered nurse and that the parents or guardians
21must indemnify and hold harmless the school district, public
22school, charter school, or nonpublic school and its employees
23and agents against any claims, except a claim based on willful
24and wanton conduct, arising out of the administration of
25asthma medication, an epinephrine injector, or an opioid
26antagonist regardless of whether authorization was given by

 

 

HB3613 Engrossed- 8 -LRB103 30213 RJT 56641 b

1the pupil's parents or guardians or by the pupil's physician,
2physician assistant, or advanced practice registered nurse.
3    (c-5) When a school nurse or trained personnel administers
4an undesignated epinephrine injector to a person whom the
5school nurse or trained personnel in good faith believes is
6having an anaphylactic reaction, administers an opioid
7antagonist to a person whom the school nurse or trained
8personnel in good faith believes is having an opioid overdose,
9or administers undesignated asthma medication to a person whom
10the school nurse or trained personnel in good faith believes
11is having respiratory distress, notwithstanding the lack of
12notice to the parents or guardians of the pupil or the absence
13of the parents or guardians signed statement acknowledging no
14liability, except for willful and wanton conduct, the school
15district, public school, charter school, or nonpublic school
16and its employees and agents, and a physician, a physician
17assistant, or an advanced practice registered nurse providing
18standing protocol and a prescription for undesignated
19epinephrine injectors, an opioid antagonist, or undesignated
20asthma medication, are to incur no liability or professional
21discipline, except for willful and wanton conduct, as a result
22of any injury arising from the use of an undesignated
23epinephrine injector, the use of an opioid antagonist, or the
24use of undesignated asthma medication, regardless of whether
25authorization was given by the pupil's parents or guardians or
26by the pupil's physician, physician assistant, or advanced

 

 

HB3613 Engrossed- 9 -LRB103 30213 RJT 56641 b

1practice registered nurse.
2    (d) The permission for self-administration and self-carry
3of asthma medication or the self-administration and self-carry
4of an epinephrine injector is effective for the school year
5for which it is granted and shall be renewed each subsequent
6school year upon fulfillment of the requirements of this
7Section.
8    (e) Provided that the requirements of this Section are
9fulfilled, a pupil with asthma may self-administer and
10self-carry his or her asthma medication or a pupil may
11self-administer and self-carry an epinephrine injector (i)
12while in school, (ii) while at a school-sponsored activity,
13(iii) while under the supervision of school personnel, or (iv)
14before or after normal school activities, such as while in
15before-school or after-school care on school-operated property
16or while being transported on a school bus.
17    (e-5) Provided that the requirements of this Section are
18fulfilled, a school nurse or trained personnel may administer
19an undesignated epinephrine injector to any person whom the
20school nurse or trained personnel in good faith believes to be
21having an anaphylactic reaction (i) while in school, (ii)
22while at a school-sponsored activity, (iii) while under the
23supervision of school personnel, or (iv) before or after
24normal school activities, such as while in before-school or
25after-school care on school-operated property or while being
26transported on a school bus. A school nurse or trained

 

 

HB3613 Engrossed- 10 -LRB103 30213 RJT 56641 b

1personnel may carry undesignated epinephrine injectors on his
2or her person while in school or at a school-sponsored
3activity.
4    (e-10) Provided that the requirements of this Section are
5fulfilled, a school nurse or trained personnel may administer
6an opioid antagonist to any person whom the school nurse or
7trained personnel in good faith believes to be having an
8opioid overdose (i) while in school, (ii) while at a
9school-sponsored activity, (iii) while under the supervision
10of school personnel, or (iv) before or after normal school
11activities, such as while in before-school or after-school
12care on school-operated property. A school nurse or trained
13personnel may carry an opioid antagonist on his or her person
14while in school or at a school-sponsored activity.
15    (e-15) If the requirements of this Section are met, a
16school nurse or trained personnel may administer undesignated
17asthma medication to any person whom the school nurse or
18trained personnel in good faith believes to be experiencing
19respiratory distress (i) while in school, (ii) while at a
20school-sponsored activity, (iii) while under the supervision
21of school personnel, or (iv) before or after normal school
22activities, including before-school or after-school care on
23school-operated property. A school nurse or trained personnel
24may carry undesignated asthma medication on his or her person
25while in school or at a school-sponsored activity.
26    (f) The school district, public school, charter school, or

 

 

HB3613 Engrossed- 11 -LRB103 30213 RJT 56641 b

1nonpublic school may maintain a supply of undesignated
2epinephrine injectors in any secure location that is
3accessible before, during, and after school where an allergic
4person is most at risk, including, but not limited to,
5classrooms and lunchrooms. A physician, a physician assistant
6who has prescriptive authority in accordance with Section 7.5
7of the Physician Assistant Practice Act of 1987, or an
8advanced practice registered nurse who has prescriptive
9authority in accordance with Section 65-40 of the Nurse
10Practice Act may prescribe undesignated epinephrine injectors
11in the name of the school district, public school, charter
12school, or nonpublic school to be maintained for use when
13necessary. Any supply of epinephrine injectors shall be
14maintained in accordance with the manufacturer's instructions.
15    The school district, public school, charter school, or
16nonpublic school may maintain a supply of an opioid antagonist
17in any secure location where an individual may have an opioid
18overdose. A health care professional who has been delegated
19prescriptive authority for opioid antagonists in accordance
20with Section 5-23 of the Substance Use Disorder Act may
21prescribe opioid antagonists in the name of the school
22district, public school, charter school, or nonpublic school,
23to be maintained for use when necessary. Any supply of opioid
24antagonists shall be maintained in accordance with the
25manufacturer's instructions.
26    The school district, public school, charter school, or

 

 

HB3613 Engrossed- 12 -LRB103 30213 RJT 56641 b

1nonpublic school may maintain a supply of asthma medication in
2any secure location that is accessible before, during, or
3after school where a person is most at risk, including, but not
4limited to, a classroom or the nurse's office. A physician, a
5physician assistant who has prescriptive authority under
6Section 7.5 of the Physician Assistant Practice Act of 1987,
7or an advanced practice registered nurse who has prescriptive
8authority under Section 65-40 of the Nurse Practice Act may
9prescribe undesignated asthma medication in the name of the
10school district, public school, charter school, or nonpublic
11school to be maintained for use when necessary. Any supply of
12undesignated asthma medication must be maintained in
13accordance with the manufacturer's instructions.
14    A school district that provides special educational
15facilities for children with disabilities under Section
1614-4.01 of this Code may maintain a supply of undesignated
17oxygen tanks in any secure location that is accessible before,
18during, and after school where a person with developmental
19disabilities is most at risk, including, but not limited to,
20classrooms and lunchrooms. A physician, a physician assistant
21who has prescriptive authority in accordance with Section 7.5
22of the Physician Assistant Practice Act of 1987, or an
23advanced practice registered nurse who has prescriptive
24authority in accordance with Section 65-40 of the Nurse
25Practice Act may prescribe undesignated oxygen tanks in the
26name of the school district that provides special educational

 

 

HB3613 Engrossed- 13 -LRB103 30213 RJT 56641 b

1facilities for children with disabilities under Section
214-4.01 of this Code to be maintained for use when necessary.
3Any supply of oxygen tanks shall be maintained in accordance
4with the manufacturer's instructions and with the local fire
5department's rules.
6    (f-3) Whichever entity initiates the process of obtaining
7undesignated epinephrine injectors and providing training to
8personnel for carrying and administering undesignated
9epinephrine injectors shall pay for the costs of the
10undesignated epinephrine injectors.
11    (f-5) Upon any administration of an epinephrine injector,
12a school district, public school, charter school, or nonpublic
13school must immediately activate the EMS system and notify the
14student's parent, guardian, or emergency contact, if known.
15    Upon any administration of an opioid antagonist, a school
16district, public school, charter school, or nonpublic school
17must immediately activate the EMS system and notify the
18student's parent, guardian, or emergency contact, if known.
19    (f-10) Within 24 hours of the administration of an
20undesignated epinephrine injector, a school district, public
21school, charter school, or nonpublic school must notify the
22physician, physician assistant, or advanced practice
23registered nurse who provided the standing protocol and a
24prescription for the undesignated epinephrine injector of its
25use.
26    Within 24 hours after the administration of an opioid

 

 

HB3613 Engrossed- 14 -LRB103 30213 RJT 56641 b

1antagonist, a school district, public school, charter school,
2or nonpublic school must notify the health care professional
3who provided the prescription for the opioid antagonist of its
4use.
5    Within 24 hours after the administration of undesignated
6asthma medication, a school district, public school, charter
7school, or nonpublic school must notify the student's parent
8or guardian or emergency contact, if known, and the physician,
9physician assistant, or advanced practice registered nurse who
10provided the standing protocol and a prescription for the
11undesignated asthma medication of its use. The district or
12school must follow up with the school nurse, if available, and
13may, with the consent of the child's parent or guardian,
14notify the child's health care provider of record, as
15determined under this Section, of its use.
16    (g) Prior to the administration of an undesignated
17epinephrine injector, trained personnel must submit to the
18school's administration proof of completion of a training
19curriculum to recognize and respond to anaphylaxis that meets
20the requirements of subsection (h) of this Section. Training
21must be completed annually. The school district, public
22school, charter school, or nonpublic school must maintain
23records related to the training curriculum and trained
24personnel.
25    Prior to the administration of an opioid antagonist,
26trained personnel must submit to the school's administration

 

 

HB3613 Engrossed- 15 -LRB103 30213 RJT 56641 b

1proof of completion of a training curriculum to recognize and
2respond to an opioid overdose, which curriculum must meet the
3requirements of subsection (h-5) of this Section. Training
4must be completed annually. Trained personnel must also submit
5to the school's administration proof of cardiopulmonary
6resuscitation and automated external defibrillator
7certification. The school district, public school, charter
8school, or nonpublic school must maintain records relating to
9the training curriculum and the trained personnel.
10    Prior to the administration of undesignated asthma
11medication, trained personnel must submit to the school's
12administration proof of completion of a training curriculum to
13recognize and respond to respiratory distress, which must meet
14the requirements of subsection (h-10) of this Section.
15Training must be completed annually, and the school district,
16public school, charter school, or nonpublic school must
17maintain records relating to the training curriculum and the
18trained personnel.
19    (h) A training curriculum to recognize and respond to
20anaphylaxis, including the administration of an undesignated
21epinephrine injector, may be conducted online or in person.
22    Training shall include, but is not limited to:
23        (1) how to recognize signs and symptoms of an allergic
24    reaction, including anaphylaxis;
25        (2) how to administer an epinephrine injector; and
26        (3) a test demonstrating competency of the knowledge

 

 

HB3613 Engrossed- 16 -LRB103 30213 RJT 56641 b

1    required to recognize anaphylaxis and administer an
2    epinephrine injector.
3    Training may also include, but is not limited to:
4        (A) a review of high-risk areas within a school and
5    its related facilities;
6        (B) steps to take to prevent exposure to allergens;
7        (C) emergency follow-up procedures, including the
8    importance of calling 9-1-1 or, if 9-1-1 is not available,
9    other local emergency medical services;
10        (D) how to respond to a student with a known allergy,
11    as well as a student with a previously unknown allergy;
12        (E) other criteria as determined in rules adopted
13    pursuant to this Section; and
14        (F) any policy developed by the State Board of
15    Education under Section 2-3.190.
16    In consultation with statewide professional organizations
17representing physicians licensed to practice medicine in all
18of its branches, registered nurses, and school nurses, the
19State Board of Education shall make available resource
20materials consistent with criteria in this subsection (h) for
21educating trained personnel to recognize and respond to
22anaphylaxis. The State Board may take into consideration the
23curriculum on this subject developed by other states, as well
24as any other curricular materials suggested by medical experts
25and other groups that work on life-threatening allergy issues.
26The State Board is not required to create new resource

 

 

HB3613 Engrossed- 17 -LRB103 30213 RJT 56641 b

1materials. The State Board shall make these resource materials
2available on its Internet website.
3    (h-5) A training curriculum to recognize and respond to an
4opioid overdose, including the administration of an opioid
5antagonist, may be conducted online or in person. The training
6must comply with any training requirements under Section 5-23
7of the Substance Use Disorder Act and the corresponding rules.
8It must include, but is not limited to:
9        (1) how to recognize symptoms of an opioid overdose;
10        (2) information on drug overdose prevention and
11    recognition;
12        (3) how to perform rescue breathing and resuscitation;
13        (4) how to respond to an emergency involving an opioid
14    overdose;
15        (5) opioid antagonist dosage and administration;
16        (6) the importance of calling 9-1-1 or, if 9-1-1 is
17    not available, other local emergency medical services;
18        (7) care for the overdose victim after administration
19    of the overdose antagonist;
20        (8) a test demonstrating competency of the knowledge
21    required to recognize an opioid overdose and administer a
22    dose of an opioid antagonist; and
23        (9) other criteria as determined in rules adopted
24    pursuant to this Section.
25    (h-10) A training curriculum to recognize and respond to
26respiratory distress, including the administration of

 

 

HB3613 Engrossed- 18 -LRB103 30213 RJT 56641 b

1undesignated asthma medication, may be conducted online or in
2person. The training must include, but is not limited to:
3        (1) how to recognize symptoms of respiratory distress
4    and how to distinguish respiratory distress from
5    anaphylaxis;
6        (2) how to respond to an emergency involving
7    respiratory distress;
8        (3) asthma medication dosage and administration;
9        (4) the importance of calling 9-1-1 or, if 9-1-1 is
10    not available, other local emergency medical services;
11        (5) a test demonstrating competency of the knowledge
12    required to recognize respiratory distress and administer
13    asthma medication; and
14        (6) other criteria as determined in rules adopted
15    under this Section.
16    (i) Within 3 days after the administration of an
17undesignated epinephrine injector by a school nurse, trained
18personnel, or a student at a school or school-sponsored
19activity, the school must report to the State Board of
20Education in a form and manner prescribed by the State Board
21the following information:
22        (1) age and type of person receiving epinephrine
23    (student, staff, visitor);
24        (2) any previously known diagnosis of a severe
25    allergy;
26        (3) trigger that precipitated allergic episode;

 

 

HB3613 Engrossed- 19 -LRB103 30213 RJT 56641 b

1        (4) location where symptoms developed;
2        (5) number of doses administered;
3        (6) type of person administering epinephrine (school
4    nurse, trained personnel, student); and
5        (7) any other information required by the State Board.
6    If a school district, public school, charter school, or
7nonpublic school maintains or has an independent contractor
8providing transportation to students who maintains a supply of
9undesignated epinephrine injectors, then the school district,
10public school, charter school, or nonpublic school must report
11that information to the State Board of Education upon adoption
12or change of the policy of the school district, public school,
13charter school, nonpublic school, or independent contractor,
14in a manner as prescribed by the State Board. The report must
15include the number of undesignated epinephrine injectors in
16supply.
17    (i-5) Within 3 days after the administration of an opioid
18antagonist by a school nurse or trained personnel, the school
19must report to the State Board of Education, in a form and
20manner prescribed by the State Board, the following
21information:
22        (1) the age and type of person receiving the opioid
23    antagonist (student, staff, or visitor);
24        (2) the location where symptoms developed;
25        (3) the type of person administering the opioid
26    antagonist (school nurse or trained personnel); and

 

 

HB3613 Engrossed- 20 -LRB103 30213 RJT 56641 b

1        (4) any other information required by the State Board.
2    (i-10) Within 3 days after the administration of
3undesignated asthma medication by a school nurse, trained
4personnel, or a student at a school or school-sponsored
5activity, the school must report to the State Board of
6Education, on a form and in a manner prescribed by the State
7Board of Education, the following information:
8        (1) the age and type of person receiving the asthma
9    medication (student, staff, or visitor);
10        (2) any previously known diagnosis of asthma for the
11    person;
12        (3) the trigger that precipitated respiratory
13    distress, if identifiable;
14        (4) the location of where the symptoms developed;
15        (5) the number of doses administered;
16        (6) the type of person administering the asthma
17    medication (school nurse, trained personnel, or student);
18        (7) the outcome of the asthma medication
19    administration; and
20        (8) any other information required by the State Board.
21    (j) By October 1, 2015 and every year thereafter, the
22State Board of Education shall submit a report to the General
23Assembly identifying the frequency and circumstances of
24undesignated epinephrine and undesignated asthma medication
25administration during the preceding academic year. Beginning
26with the 2017 report, the report shall also contain

 

 

HB3613 Engrossed- 21 -LRB103 30213 RJT 56641 b

1information on which school districts, public schools, charter
2schools, and nonpublic schools maintain or have independent
3contractors providing transportation to students who maintain
4a supply of undesignated epinephrine injectors. This report
5shall be published on the State Board's Internet website on
6the date the report is delivered to the General Assembly.
7    (j-5) Annually, each school district, public school,
8charter school, or nonpublic school shall request an asthma
9action plan from the parents or guardians of a pupil with
10asthma. If provided, the asthma action plan must be kept on
11file in the office of the school nurse or, in the absence of a
12school nurse, the school administrator. Copies of the asthma
13action plan may be distributed to appropriate school staff who
14interact with the pupil on a regular basis, and, if
15applicable, may be attached to the pupil's federal Section 504
16plan or individualized education program plan.
17    (j-10) To assist schools with emergency response
18procedures for asthma, the State Board of Education, in
19consultation with statewide professional organizations with
20expertise in asthma management and a statewide organization
21representing school administrators, shall develop a model
22asthma episode emergency response protocol before September 1,
232016. Each school district, charter school, and nonpublic
24school shall adopt an asthma episode emergency response
25protocol before January 1, 2017 that includes all of the
26components of the State Board's model protocol.

 

 

HB3613 Engrossed- 22 -LRB103 30213 RJT 56641 b

1    (j-15) Every 2 years, school personnel who work with
2pupils shall complete an in-person or online training program
3on the management of asthma, the prevention of asthma
4symptoms, and emergency response in the school setting. In
5consultation with statewide professional organizations with
6expertise in asthma management, the State Board of Education
7shall make available resource materials for educating school
8personnel about asthma and emergency response in the school
9setting.
10    (j-20) On or before October 1, 2016 and every year
11thereafter, the State Board of Education shall submit a report
12to the General Assembly and the Department of Public Health
13identifying the frequency and circumstances of opioid
14antagonist administration during the preceding academic year.
15This report shall be published on the State Board's Internet
16website on the date the report is delivered to the General
17Assembly.
18    (k) The State Board of Education may adopt rules necessary
19to implement this Section.
20    (l) Nothing in this Section shall limit the amount of
21epinephrine injectors that any type of school or student may
22carry or maintain a supply of.
23(Source: P.A. 101-81, eff. 7-12-19; 102-413, eff. 8-20-21;
24102-813, eff. 5-13-22.)